Furthermore, patients receiving PPIs frequently represent a high-risk co-morbid population: Indeed, patients on concomitant PPI treatment in studies showing adverse effects of PPIs had more frequently co-morbidities including diabetes, renal dysfunction, hypertension, a history of myocardial infarction, and heart failure.23 Such co-morbidities are obviously associated with worse clinical outcome.